{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:10:12Z","timestamp":1778796612127,"version":"3.51.4"},"reference-count":20,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,9,12]]},"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p><jats:italic>Helicobacter pylori<\/jats:italic>(Hp) is an important pathogenic factor for chronic gastritis, peptic ulcer, gastric cancer, gastric mucosa-associated lymphoid tissue lymphoma and other diseases. In China, the Hp infection rate is high, but the eradication rate is decreasing. A large number of literatures have shown that the addition of<jats:italic>Lactobacillus acidophilus<\/jats:italic>can improve the Hp eradication rate and reduce the side effects of antibiotic treatments. At present, the exact mechanism and curative effect of<jats:italic>L. acidophilus<\/jats:italic>in the eradication of Hp have not yet been determined, and the conclusions obtained from relevant meta-analyses at home and abroad are different. Thus, it is very necessary and urgent to further complete a high-quality, clinical, randomised controlled trial research. If this study is successful, it can provide a new idea and a plan for Hp eradication therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This study is a prospective, randomised controlled, single-blinded, parallel-design trial. We will randomly assign 526 adult patients (\u226518 years but &lt;70 years) with Hp confirmed positive by the kit for 14C-urea breath test. Eligible subjects were randomly divided into two groups (group A and group B), with 263 subjects in each group. Group A is a quadruple therapy group, while group B is an<jats:italic>L. acidophilus<\/jats:italic>tablets combined with quadruple therapy group. All patients were examined by gastroscopy, and 50 patients in each group will be placed under gastric pH monitor. The Hp eradication rate is the primary outcome. The secondary outcomes include gastric pH situation and adverse drug reactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The study protocol has been approved by the Clinical Research Ethics Committees of Chongqing University Cancer Hospital and Chongqing Cancer Hospital (2018[012]). The results from this trial will be submitted for publication in peer-reviewed journals and will be presented at national and international conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>ChiCTR17014185; Pre-results.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2018-023131","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T05:15:52Z","timestamp":1540790152000},"page":"e023131","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of compound<i>Lactobacillus acidophilus<\/i>tablets combined with quadruple therapy for<i>Helicobacter pylori<\/i>eradication and its correlation with pH value in the stomach: a study protocol of a randomised, assessor-blinded, single-centre study"],"prefix":"10.1136","volume":"8","author":[{"given":"Wen","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,10,28]]},"reference":[{"key":"2024051713374606000_8.10.e023131.1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hel.12332","article-title":"Epidemiology of helicobacter pylori infection","volume":"21","author":"Leja","year":"2016","journal-title":"Helicobacter"},{"key":"2024051713374606000_8.10.e023131.2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"2024051713374606000_8.10.e023131.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2007.00518.x"},{"key":"2024051713374606000_8.10.e023131.4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"2024051713374606000_8.10.e023131.5","unstructured":"\u7b2c\u4e94\u6b21\u5168\u56fd\u5e7d\u95e8\u87ba\u6746\u83cc\u611f\u67d3\u5904\u7406\u5171\u8bc6\u62a5\u544a. \u4e2d\u534e\u533b\u5b66\u4f1a\u6d88\u5316\u75c5\u5b66\u5206\u4f1a\u5e7d\u95e8\u87ba\u6746\u83cc\u548c\u6d88\u5316\u6027\u6e83\u75a1\u5b66\u7ec4,\u5168\u56fd\u5e7d\u95e8\u87ba\u6746\u83cc\u7814\u7a76\u534f\u4f5c\u7ec4,\u5218\u6587\u5fe0,\u8c22\u52c7,\u9646\u7ea2\u7b49. [J] \u4e2d\u534e\u6d88\u5316\u6742\u5fd7 2017;6."},{"key":"2024051713374606000_8.10.e023131.6","doi-asserted-by":"crossref","unstructured":"Yong X , etal . WJG. 2014;20:14973.","DOI":"10.3748\/wjg.v20.i40.14973"},{"key":"2024051713374606000_8.10.e023131.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151893","article-title":"Helicobacter pylori eradication causes perturbation of the human gut microbiome in young adults","volume":"11","author":"Yap","year":"2016","journal-title":"PLoS One"},{"key":"2024051713374606000_8.10.e023131.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2012.12.011"},{"key":"2024051713374606000_8.10.e023131.9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.mpg.0000338959.32432.c6","article-title":"Ecology of functional gastrointestinal disorders","volume":"47","author":"Saps","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024051713374606000_8.10.e023131.10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jmf.2009.1265","article-title":"In vitro inhibition of Helicobacter pylori growth and of adherence of cagA-positive strains to gastric epithelial cells by Lactobacillus paraplantarum KNUC25 isolated from kimchi","volume":"13","author":"Ki","year":"2010","journal-title":"J Med Food"},{"issue":"5-6","key":"2024051713374606000_8.10.e023131.11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/food.19870310507","article-title":"[Gastrointestinal microecology from the viewpoint of the pediatrician]","volume":"31","author":"Fiehring","year":"1987","journal-title":"Nahrung"},{"key":"2024051713374606000_8.10.e023131.12","first-page":"5","article-title":"\u5e7d\u95e8\u87ba\u6746\u83cc\u611f\u67d3\u5bf9\u80c3\u5185\u6b63\u5e38\u83cc\u7fa4\u7ed3\u6784\u7684\u5f71\u54cd","volume":"32","author":"\u5b8b\u9633","year":"2010","journal-title":"[J]. \u7b2c\u4e09\u519b\u533b\u5927\u5b66\u5b66\u62a5"},{"key":"2024051713374606000_8.10.e023131.13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4318\/tjg.2010.0090","article-title":"Efficacy of probiotics in Helicobacter pylori eradication therapy","volume":"21","author":"Ya\u015far","year":"2010","journal-title":"Turk J Gastroenterol"},{"key":"2024051713374606000_8.10.e023131.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2008.00026.x"},{"key":"2024051713374606000_8.10.e023131.15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/hel.12306","article-title":"Changes in the functional potential of the gut microbiome following probiotic supplementation during helicobacter pylori treatment","volume":"21","author":"Oh","year":"2016","journal-title":"Helicobacter"},{"key":"2024051713374606000_8.10.e023131.16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i14.4345"},{"key":"2024051713374606000_8.10.e023131.17","doi-asserted-by":"crossref","first-page":"23522","DOI":"10.1038\/srep23522","article-title":"Probiotic supplementation does not improve eradication rate of helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis","volume":"6","author":"Lu","year":"2016","journal-title":"Sci Rep"},{"key":"2024051713374606000_8.10.e023131.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151893","article-title":"Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults","volume":"11","author":"Yap","year":"2016","journal-title":"PLoS One"},{"key":"2024051713374606000_8.10.e023131.19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2024051713374606000_8.10.e023131.20","unstructured":"\u5b8b\u9633. \u5e7d\u95e8\u87ba\u6746\u83cc\u611f\u67d3\u5bf9\u80c3\u5185\u6b63\u5e38\u83cc\u7fa4\u7ed3\u6784\u7684\u5f71\u54cd \u7b2c\u4e09\u519b\u533b\u5927\u5b66\u5b66\u62a5. 2010;32."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-023131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:17:59Z","timestamp":1715987879000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-023131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,28]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1136\/bmjopen-2018-023131"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-023131","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}